EDGAR Filing Documents for 0001493152-24-020828

Form 8-K - Current report:

SEC Accession No. 0001493152-24-020828

Filing Date

2024-05-21

Accepted

2024-05-21 09:10:03

Documents

Period of Report

2024-05-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	93274
2		ex3-1.htm	EX-3.1	330927
3		ex3-2.htm	EX-3.2	391964
4		ex3-3.htm	EX-3.3	28235
5		ex4-1.htm	EX-4.1	213534
6		ex4-2.htm	EX-4.2	213501
7		ex4-3.htm	EX-4.3	223416
8		ex4-4.htm	EX-4.4	223223
9		ex10-1.htm	EX-10.1	355526
10		ex10-2.htm	EX-10.2	326739
11		ex10-3.htm	EX-10.3	177031
12		ex10-4.htm	EX-10.4	189480
13		ex10-5.htm	EX-10.5	69771
14		ex99-1.htm	EX-99.1	18548
	Complete submission text file	0001493152-24-020828.txt		3641083

Data Files

Seq	Description	Document	Type	Size
15	XBRL SCHEMA FILE	mymd-20240520.xsd	EX-101.SCH	3003
16	XBRL LABEL FILE	mymd-20240520_lab.xml	EX-101.LAB	34240
17	XBRL PRESENTATION FILE	mymd-20240520_pre.xml	EX-101.PRE	22351
29	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3949

Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205

Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698

MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)